Tumour agnostic therapy demonstrates sustained efficacy

Concerns over NHS Test and Trace system exacerbated by continuing rise in cases

The drug is the first and only therapy for the ultra rare condition Familial Chylomicronaemia Syndrome (FCS)

For the first time, scientists solved the high-resolution structure of these compounds when they are actively bound to […]

Updated Date: Thu, 10 Sep 2020 00:00:00 EDT

Updated Date: Thu, 10 Sep 2020 00:00:00 EDT

Updated Date: Thu, 10 Sep 2020 00:00:00 EDT

Updated Date: Thu, 10 Sep 2020 00:00:00 EDT

Updated Date: Thu, 10 Sep 2020 00:00:00 EDT

Moderna CEO expects to know by November whether coronavirus vaccine works: report esagonowsky Thu, 09/17/2020 – 11:09